Breaking News, Promotions & Moves

Achillion Appoints CMO

Expands clinical operations team

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

David Apelian, M.D., Ph.D., has been appointed executive vice president and chief medical officer at Achillion Pharmaceuticals. Dr. Apelian will assume responsibility for the clinical development of the company’s portfolio of HCV compounds. In addition, Kevin Kucharski, will serve as senior vice president of Clinical Operations. Mr. Kucharski was formerly head of clinical operations at Pharmasset   Dr. Apelian brings more than 13 years of industry experience from Bristol-Myers Squibb, Sche...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters